Does EVEROLIMUS Cause Breast cancer recurrent? 83 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Breast cancer recurrent have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.2% of all adverse event reports for EVEROLIMUS.
83
Reports of Breast cancer recurrent with EVEROLIMUS
0.2%
of all EVEROLIMUS reports
13
Deaths
14
Hospitalizations
How Dangerous Is Breast cancer recurrent From EVEROLIMUS?
Of the 83 reports, 13 (15.7%) resulted in death, 14 (16.9%) required hospitalization, and 6 (7.2%) were considered life-threatening.
Is Breast cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 83 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Breast cancer recurrent?
LETROZOLE (285)
TRASTUZUMAB (268)
TAMOXIFEN (260)
FULVESTRANT (219)
ANASTROZOLE (214)
CYCLOPHOSPHAMIDE (182)
RIBOCICLIB (180)
PACLITAXEL (151)
DOCETAXEL (138)
PALBOCICLIB (126)
Which EVEROLIMUS Alternatives Have Lower Breast cancer recurrent Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE